Giving Patients a Voice: Enhancing Patient-Centered Care in Psoriatic Arthritis

Thursday, January 26, 2023, 8:00 AM - Thursday, January 25, 2024, 11:59 PM

AMA PRA Category 1 Credits™ (0.50 hours), AMA PRA Category 1 Credits™ Designated (0.50 hours)


Rheumatology experts discuss new and emerging therapies for psoriatic arthritis and best practices for engaging patients in shared decision-making. The goal of this activity is to improve the knowledge and competence of rheumatologists, rheumatology advanced practice providers, and other healthcare professionals to equip themselves and their patients with skills and information to alleviate patient burden and improve disease outcomes.

There are no fees for participating in and receiving CME credit for this online activity.

Click register now, to access this activity.

This activity can be accessed using the following url: https://www.clinicaloptions.com/immunology/programs/2022/psoriaticarthritis/video-module/vm1#

1. Identify burdens and challenges that typically impact patients with psoriatic arthritis and juvenile psoriatic arthritis;
2. Apply clinical trial data of new and emerging therapies when creating care plans for patients with psoriatic arthritis and juvenile psoriatic arthritis;
3. Integrate shared decision-making practices to ensure patients with psoriatic arthritis and juvenile psoriatic arthritis have a voice in their disease management decisions.

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

The University of Cincinnati and Clinical Care Options are accredited by the ACCME to provide continuing medical education for physicians, and have collaborated to design and execute this activity.

For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for activity.

Provided by the University of Cincinnati, in collaboration with Clinical Care Options.

Clinical Care Options, LLC (CCO) and the  University of Cincinnati requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Statement
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by healthcare professionals without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

COI / Disclosure of Relationships with Ineligible Entities

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24 months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify from involvement in the planning and implementation of accredited continuing education any individuals (1) who refuse to provide this information or (2) whose conflicts of interests cannot be mitigated.

*Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant relationships have been mitigated. The following disclosures were made:

FACULTY DISCLOSURES 

Daniel Lovell, MD, MPH
Joseph E. Levinson Professor of Pediatrics
Division of Rheumatology
Department of Pediatrics
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio

Consultant: Abbott, AstraZeneca, GlaxoSmithKline, NIH-NIAMS, Novartis, Pfizer, United Bioscience Corporation;
Advisor: Pfizer;
Researcher: AbbVie, Bristol-Myers Squibb, Janssen, NIH/NICHD, Novartis, Roche

Pamela Weiss, MD, MSCe
Associate Professor of Pediatrics and Epidemiology
Childrens Hospital of Philadelphia
Philadelphia, Pennsylvania

Consultant/Advisor/Speaker: Lilly, Novartis, Pfizer; 
Researcher: PCORI, NIH, Spondylitis Association of America

The planners and content peer reviewers from the University of Cincinnati and Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant relationships have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

This educational activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.